ENLANPPI
Live / Allowed — Notice of allowance issued (as of 16 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99075149
- Mark type
- Stylized text
- Filed
- 10 Mar 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Gregory J. Chinlund
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations and substances for the treatment of bone diseases and disorders; Pharmaceutical preparations and substances for the treatment of pathological calcification; Pharmaceutical preparations and substances for the treatment of blood plasma pyrophosphate deficiency disorders; Pharmaceutical preparations and substances for the treatment of kidney diseases and disorders
Owner
- Inozyme Pharma, Inc., Boston, MA, US
- Inozyme Pharma, Inc., Boston, MA, US
Prosecution history
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
- 07 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
- 07 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
- 19 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED